AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of Life Sciences Lending
The outlook for Life Sciences lending has long been positive. The current combination of strong underlying fundamentals, limited financing options, and deflated valuations has made the prognosis even better. In early 2023, retail investors' concerns about deteriorating credit quality in the loan market have appeared to outweigh the appeal of rising yields which now top 10% on average.